Obitazidine fumarate
- Generic Name
- Obitazidine fumarate
SM-1 vs. an Active Comparator in A Model of Transient Insomnia
- First Posted Date
- 2020-05-20
- Last Posted Date
- 2020-05-20
- Lead Sponsor
- Sequential Medicine Ltd
- Target Recruit Count
- 14
- Registration Number
- NCT04396327
- Locations
- 🇺🇸
Clinilabs Drug Development Corporation, New York, New York, United States
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
- First Posted Date
- 2017-11-09
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Sequential Medicine Ltd
- Registration Number
- NCT03338764
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2019-06-05
- Lead Sponsor
- Sequential Medicine Ltd
- Target Recruit Count
- 85
- Registration Number
- NCT03331042
- Locations
- 🇺🇸
Clinilabs, Inc., New York, New York, United States
🇺🇸NeuroTrials Research, Inc., Atlanta, Georgia, United States
Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia
- First Posted Date
- 2016-02-02
- Last Posted Date
- 2018-03-06
- Lead Sponsor
- Sequential Medicine Ltd
- Target Recruit Count
- 39
- Registration Number
- NCT02671760
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath